More SEC Filings
View Older Stories View Newer Stories-
Form 4 ADIAL PHARMACEUTICALS, For: Mar 25 Filed by: Newman James W. Jr.
-
Form 4 CBRE GROUP, INC. For: Mar 25 Filed by: Dhandapani Chandra
-
Form 4 CBRE GROUP, INC. For: Mar 25 Filed by: Durburg John E
-
Form 4 RumbleOn, Inc. For: Mar 25 Filed by: Stone House Capital Management, LLC
-
Form 4 CBRE GROUP, INC. For: Mar 25 Filed by: Giamartino Emma E.
-
Form 4 CBRE GROUP, INC. For: Mar 25 Filed by: Kohli Vikramaditya
-
Form 4 ARDELYX, INC. For: Mar 25 Filed by: Kelliher Mike
-
Form 3 ARDELYX, INC. For: Mar 25 Filed by: Kelliher Mike
-
Form 4 CBRE GROUP, INC. For: Mar 25 Filed by: Queenan Daniel G
-
Form X-17A-5 GEMINI CAPITAL L.L.C. For: Dec 31
-
Form 4 Axos Financial, Inc. For: Mar 23 Filed by: Walsh Derrick
-
Form 4 Axos Financial, Inc. For: Mar 23 Filed by: Tolla John Charles
-
Form 4 Axos Financial, Inc. For: Mar 23 Filed by: Swanson Brian D
-
Form 4 Axos Financial, Inc. For: Mar 23 Filed by: PARK DAVID X
-
Form 4 ADIAL PHARMACEUTICALS, For: Mar 25 Filed by: Truluck Joseph
-
Form 4 Axos Financial, Inc. For: Mar 23 Filed by: MATSUMOTO RAYMOND D
-
Form 4 Axos Financial, Inc. For: Mar 23 Filed by: Constantine Thomas M
-
Form 4 ADIAL PHARMACEUTICALS, For: Mar 25 Filed by: Claiborne Cary J
-
Form 4 Axos Financial, Inc. For: Mar 23 Filed by: Bar-Adon Eshel
-
Form 4 ADIAL PHARMACEUTICALS, For: Mar 25 Filed by: Anderson J. Kermit
-
Form 4 ADIAL PHARMACEUTICALS, For: Mar 25 Filed by: Schuyler Kevin
-
Form 4 ADIAL PHARMACEUTICALS, For: Mar 25 Filed by: Goodman Tony
-
Form 4 WILLIS LEASE FINANCE For: Mar 26 Filed by: HUNZIKER HANS JORG
-
Form 4 Velo3D, Inc. For: Mar 25 Filed by: Buller Benyamin
-
Form 4 Aerovate Therapeutics, For: Mar 25 Filed by: Dake Benjamin T
-
Form 4 Cingulate Inc. For: Mar 25 Filed by: Werth Peter J.
-
Form X-17A-5 ANNEXUS SECURITIES, LLC For: Dec 31
-
Form 4 BIOXYTRAN, INC For: Mar 27 Filed by: Utter Anders
-
Form X-17A-5 MUZINICH CAPITAL LLC For: Dec 31
-
Form X-17A-5 LINCOLN FINANCIAL SECURI For: Dec 31
-
Form 4 BIOXYTRAN, INC For: Mar 27 Filed by: CONAWAY DALE H
-
Form 4 BIOXYTRAN, INC For: Mar 27 Filed by: PLATT DAVID
-
Form 4 MIRA PHARMACEUTICALS, For: Mar 25 Filed by: Shekhat Denil Nanji
-
Form 4 MIRA PHARMACEUTICALS, For: Mar 26 Filed by: Aminov Erez
-
Form 4 MIRA PHARMACEUTICALS, For: Mar 26 Filed by: Yanez Michelle
-
Form 4 MIRA PHARMACEUTICALS, For: Mar 25 Filed by: Del Giudice Matthew Paul
-
Form 4 MIRA PHARMACEUTICALS, For: Mar 25 Filed by: MacPherson Edward Clouston
-
Form 4 MIRA PHARMACEUTICALS, For: Mar 25 Filed by: Jerman Michael Allen
-
Form X-17A-5 IBN FINANCIAL SERVICES, For: Dec 31
-
Form 4 PAPA JOHNS INTERNATIONAL For: Mar 25 Filed by: Oyler Caroline Miller
-
Form 4 PAPA JOHNS INTERNATIONAL For: Mar 25 Filed by: Thanawala Ravi
-
Form 4 Progyny, Inc. For: Mar 25 Filed by: Schlanger David J
-
Form 4 BIOXYTRAN, INC For: Mar 27 Filed by: Hoberman Alan M
-
Form 144 GMS Inc. Filed by: Apolinsky Craig D
-
Form 4 LIGAND PHARMACEUTICALS For: Mar 25 Filed by: Davis Todd C
-
Form 144 Bioventus Inc. Filed by: Bihl Anthony P III
-
Form 4 Atlassian Corp For: Mar 26 Filed by: Cannon-Brookes Michael
-
Form 4 Atlassian Corp For: Mar 26 Filed by: Farquhar Scott
-
Form 4 ID Auto, Inc. For: Feb 22 Filed by: Royzenshteyn Stanislav
-
Form 4 Q32 Bio Inc. For: Mar 25 Filed by: TZIANABOS ARTHUR

